What is the UMB Institute for Clinical & Translational Research (ICTR)?
The UMB ICTR is a clinical translational research initiative supported by the UMB campus.
The UMB ICTR is a campuswide clinical translational research initiative supported by the UMB campus. The UMB ICTR provides financial support as well as infrastructure, environment, training, and workforce to invigorate, facilitate, and accelerate clinical translational research to improve patient and community health. This site will highlight ICTR-supported resources as well as other campuswide shared resources and community-engagement activities. If you are unsure of the "next steps" or have problems with the ICTR website, please email ICTR Research Navigator and visit this site often for new and expanding UMB ICTR resources. To learn more about UMB ICTR and the tremendous support from the UMB campus, visit About UMB ICTR.
SUBSCRIBE TO THE ICTR EMAIL LIST for the latest announcements about ICTR funding opportunities, Enrichment Seminar Series presentations and more.
- Funding for a Study
- Informatics Support, Cybersecurity, AI
- Biostatistical Support
- Data for Research (EPIC Clinical Data and PRC Data)
- Data Management (REDCap, Qualtrics, CTRIC db)
- High Performance Computing
- Data Storage
- Help With Developing My Protocol
- Clinical Space for My Research
- Clinical Staff for My Research
- Specimen Collection/Processing
- Volunteers for My Research
- Help with the Next Steps
- Acknowledging UMB ICTR
- Letter of Support or ICTR Facilities/Environment/Resources Document
Congratulations to the Awardees of the ICTR Inaugural CEnR Pilot Grant Round!
July 01, 2022 | The UMB ICTR Announces the ICTR 2022 Inaugural Community Engaged Research (CEnR) Pilot Grant Awardees. The CEnR pilot grant provides starter funds for projects specifically focused on innovative approaches to addressing health problems through community-engaged implementation...
UMB ICTR Announces Special Call for Applications for Nephrotic Syndrome Research Funding
June 27, 2022 | The UMB ICTR Announces a Special Call for Applications for Two Funding Opportunities Focused on the Physiology, Pathophysiology and/or Treatment of Nephrotic Syndrome: A Two-Year Pilot Grant Award and a KL2 Mentored Career Development Award. These one-time funding opportunities are supported by a Mallinckrodt Pharmaceuticals settlement managed by UMB ICTR. For more information, visit...
NIH’s All of Us Research Program Releases New COVID-19 Data. UMB has access.
September 28, 2021 | The UMB HSHSL can help UMB faculty with accessing this data. Email JP Courneya firstname.lastname@example.org or Amy Yarnell email@example.com
UMB Hosts 3rd International Conference of the Society for Interdisciplinary Placebo Studies (SIPS)
May 26, 2021 | UMB ICTR TL1 Scholars Program Director, Dr.Luana Colloca, co-chairs the planning committee for SIPS, an international association of scholars who share the goal of understanding the placebo effect in medical treatment, psychotherapy, and complementary and alternative treatment. Expert faculty from the UMB Schools of Medicine, Nursing and Pharmacy collaborated with SIPS to design an intehttps://sirdisciplinary, international scientific conference to advance the science of placebo research and ...
UMB ICTR KL2 Scholars Forging Ahead During Healthcare Crises
November 09, 2020 | While the nation is undergoing unprecedent pandemic and opioid crises, Internal KL2 Scholars from UMB’s Institute of Clinical Translational Research (ICTR) are thriving and meeting these healthcare challenges. Read more about this and other ICTR Training and Career Development News...